Supporting oncology professionals through education
The content on this site is intended for healthcare professionals only
The content on this site is intended for healthcare professionals only
A novel methodology was used successfully in the non-invasive evaluation of the mutation frequency of the PIK3CA gene in circulating tumour cells (CTCs) found in the blood of patients with metastatic hormone receptor-positive breast cancer, according to findings presented during an abstracts session at the IMPAKT Breast Cancer Conference held 7–9 May, 2015 in Brussels, Belgium.
Click here to read the article in full.
Source: ESMO
We are an independent charity and are not backed by a large company or society. We raise every penny ourselves to improve the standards of cancer care through education. You can help us continue our work to address inequalities in cancer care by making a donation.
Any donation, however small, contributes directly towards the costs of creating and sharing free oncology education.
Together we can get better outcomes for patients by tackling global inequalities in access to the results of cancer research.
Thank you for your support.